Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

BACKGROUND: Several antiplatelet medications used during and after percutaneous coronary intervention (PCI) are contraindicated for specific patient groups. A broad assessment of contraindicated medication use and associated clinical outcomes is not well described. METHODS AND RESULTS: Using nationa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Circ Cardiovasc Qual Outcomes
Egile Nagusiak: Barnes, Geoffrey D., Stanislawski, Maggie A, Liu, Wenhui, Barón, Anna E, Armstrong, Ehrin J, Ho, P. Michael, Klein, Andrew, Maddox, Thomas M., Nallamothu, Brahmajee K., Rumsfeld, John S., Tsai, Thomas T., Bradley, Steven M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4956561/
https://ncbi.nlm.nih.gov/pubmed/27245070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.115.002043
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak